Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR25F8QNG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body applicators on August 26, 2025, with completion targeted for September 17, 2025. SKYRIZI is a biologic medication indicated for the treatment of plaque psoriasis and other inflammatory dermatological conditions. The award represents a competitively awarded, non-set-aside transaction executed through AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across the Department of Defense healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen's continued role as a key vendor within the federal pharmaceutical supply chain, supporting the delivery of specialty medications and branded therapeutics to military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR25F8QNG?
SPE2DR25F8QNG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DR25F8QNG worth?
The government has obligated $11,830 on SPE2DR25F8QNG.
Is contract SPE2DR25F8QNG an order under another contract?
Yes. SPE2DR25F8QNG is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DR25F8QNG competed?
The extent of competition for SPE2DR25F8QNG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award